Abstract | AIM: The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid for mid-portion, non-insertional Achilles tendinopathy. MATERIALS AND METHODS: A prospective, open labelled, single center, pilot study was conducted. All patients enrolled received a single peri-tendinous injection of Ostenil Tendon™ (40 mg/2 ml 2% HA with 0.5% mannitol). Outcome measures were Visual Analogue Scale (VAS) pain score and Manchester-Oxford Foot Questionnaire (MOxFQ) scores at 2 weeks and at final follow at 12 weeks. Any major and minor adverse effects were recorded. To assess change in VAS and MOxFQ scores, t test and Wilcoxon signed rank test were employed. RESULTS: Seventeen patients were enrolled in this study with a mean follow-up of 12 weeks. Mean pre-injection VAS score was 9.38 cm (9-9.8), which significantly reduced post-injection to a mean score of 4.09 cm (2-8) at week-2 stage, and further improved to 3.01 cm (2-3.9) at the final follow-up (p < 0.0001). MOxFQ score showed a significant improvement from pre-injection value of 67.77 (63.03-72.55) to 31.18 (13-60) at week-2 stage, and further improved to 24.20 (15.73-32.67) at the final follow-up (p < 0.0001). The mean improvement from pre-injection to the final follow up was 43.57 (34.25-52.90). No adverse effects for injections were recorded. CONCLUSION: This small series suggests an encouraging response of a single injection of HA as an effective and safe option for non-insertional Achilles tendinopathy.
|
Authors | Brijesh Ayyaswamy, Manesh Vaghela, Elizabeth Alderton, Haroon Majeed, Rajiv Limaye |
Journal | Foot (Edinburgh, Scotland)
(Foot (Edinb))
Vol. 49
Pg. 101738
(Dec 2021)
ISSN: 1532-2963 [Electronic] Scotland |
PMID | 33132010
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Achilles Tendon
- Humans
- Hyaluronic Acid
- Pilot Projects
- Prospective Studies
- Tendinopathy
(drug therapy)
- Treatment Outcome
|